National Drinking Water Database
National Drinking Water Database - Chemical Contaminants
Di(2-Ethylhexyl) adipate
Status: Regulated - EPA has established a maximum legal limit in tapwater for this contaminant.
Di(2-Ethylhexyl) adipate is a placticizer and solvent released as a pollutant from industrial chemical factories, sewage treatment facilities and iron foundries. [read more]
Detected |
Found above health guidelines |
Found above legal limit |
|
|---|---|---|---|
| States | 24 |
2 |
- |
| Water utilities | 215 |
2 |
- |
| People Served | 4,927,752 |
3,640 |
- |
Health Concerns for Di(2-Ethylhexyl) adipate:
- Cancer
- Organ system toxicity (non-reproductive)
- Endocrine disruption
- Developmental/reproductive toxicity
- Biochemical or cellular level changes
- Ecotoxicology
- Persistence and bioaccumulation
Di(2-Ethylhexyl) adipate Exposure by State
Water utilities in 24 states have reported detecting Di(2-Ethylhexyl) adipate in treated tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies.
| State | Water Suppliers with Di(2-Ethylhexyl) adipate contamination | Water suppliers reporting Di(2-Ethylhexyl) adipate above health-based limits | ||
|---|---|---|---|---|
| Systems | Population | Systems | Population | |
| Maine | 7 | 164,080 | 1 | 2,840 |
| New Mexico | 12 | 132,009 | 1 | 800 |
| Maryland | 5 | 1,929,851 | 0 | 0 |
| Florida | 15 | 1,259,373 | 0 | 0 |
| North Carolina | 80 | 486,421 | 0 | 0 |
| Utah | 2 | 312,700 | 0 | 0 |
| Delaware | 2 | 201,369 | 0 | 0 |
| Massachusetts | 2 | 127,500 | 0 | 0 |
| Kentucky | 3 | 87,052 | 0 | 0 |
| Texas | 5 | 53,652 | 0 | 0 |
| Iowa | 27 | 41,908 | 0 | 0 |
| California | 2 | 26,815 | 0 | 0 |
| Indiana | 4 | 25,429 | 0 | 0 |
| Nebraska | 2 | 23,240 | 0 | 0 |
| Rhode Island | 1 | 21,900 | 0 | 0 |
| Illinois | 4 | 10,440 | 0 | 0 |
| Connecticut | 17 | 10,199 | 0 | 0 |
| Arkansas | 4 | 4,785 | 0 | 0 |
| New York | 2 | 3,900 | 0 | 0 |
| Wisconsin | 12 | 3,827 | 0 | 0 |
| New Hampshire | 3 | 860 | 0 | 0 |
| Virginia | 1 | 187 | 0 | 0 |
| Montana | 2 | 165 | 0 | 0 |
| Idaho | 1 | 90 | 0 | 0 |
| Total | 215 | 4,927,752 | 2 | 3,640 |
The Most Polluted Communities
215 water utilities reported detecting Di(2-Ethylhexyl) adipate in tap water since 2004, according to EWG's analysis of water quality data supplied by state water agencies
Ranked by highest average Di(2-Ethylhexyl) adipate level
| Rank | System | Population Served | Positive test results of total reported tests | Average Level (Range) |
|---|---|---|---|---|
| 1 | Mora Mdwca Mora, NM | 800 | 1 of 2 | 41.25 ppb (0 to 82.5 ppb) |
| 2 | Rio EN Medio Mdwca Tesuque, NM | 130 | 1 of 3 | 9.87 ppb (0 to 29.6 ppb) |
| 3 | LA Cienega Lakeside Mhp Santa Fe, NM | 60 | 1 of 2 | 9.6 ppb (0 to 19.2 ppb) |
| 4 | Tesuque Mdwca Tesuque, NM | 370 | 1 of 2 | 9.6 ppb (0 to 19.2 ppb) |
| 5 | Loring Utilities Limestone, ME | 1,409 | 1 of 3 | 7.33 ppb (0 to 22 ppb) |
| 6 | Stockdale Ranchos Mutual Water Co Bakersfield, CA | 300 | 1 of 1 | 5.7 ppb (5.7 ppb) |
| 7 | Eagle Chateau Apts Kenosha, WI | 125 | 1 of 1 | 4.8 ppb (4.8 ppb) |
| 8 | Madawaska Water District Madawaska, ME | 2,840 | 1 of 9 | 3.78 ppb (0 to 34 ppb) |
| 9 | Hog Creek Wsc Valley Mills, TX | 657 | 1 of 1 | 3.6 ppb (3.6 ppb) |
| 10 | Mountain View Park Estates Columbia, NH | 45 | 1 of 3 | 2.9 ppb (0 to 8.7 ppb) |
Health Based Limits for Di(2-Ethylhexyl) adipate
| Standard | Description | Level |
|---|---|---|
| One in one million (10-6) Cancer Risk | The concentration of a chemical in drinking water corresponding to an excess estimated lifetime cancer risk of 1 in 1,000,000. Source: U.S. Environmental Protection Agency. | 30 ppb |
| California Public Health Goals | Defined by the State of California Office of Environmental Health Hazard Assessment (OEHHA) as the level of contaminant that is allowed in drinking water. For acutely toxic substances, levels are set at which scientific evidence indicates that no known or anticipated adverse effects on health will occur, plus an adequate margin-of safety. PHGs for carcinogens or other substances which can cause chronic disease shall be based solely on health effects without regard to cost impacts and shall be set at levels which OEHHA has determined do not pose any significant risk to health. | 200 ppb |
| Maximum Contaminant Limit (MCL) | The enforceable standard which defines the highest level of a contaminant that is allowed in drinking water. MCLs are set as close to health-based limits (Maximum Contaminant Level Goals, or MCLGs) as feasible using the best available analytical and treatment technologies and taking cost into consideration. Source: U.S. Environmental Protection Agency. | 400 ppb |
| Maximum Contaminant Limit Goal (MCLG) | A non-enforceable health goal that is set at a level at which no known or anticipated adverse effect on the health of persons occurs and which allows an adequate margin of safety. Source: U.S. Environmental Protection Agency. | 400 ppb |
| Lifetime health-based limit, non-cancer risk | Concentration of a chemical in drinking water that is not expected to cause any adverse, noncarcinogenic health effects for a lifetime of exposure. The Lifetime health-based limit (or Health Advisory, HA) is based on exposure for a a 70-kg adult consuming 2 liters of water per day. Source: U.S. Environmental Protection Agency. | 400 ppb |
| One in ten thousand (10-4) Cancer Risk | The concentration of a chemical in drinking water corresponding to an excess estimated lifetime cancer risk of 1 in 10,000. Source: U.S. Environmental Protection Agency. | 3000 ppb |
| Children's health-based limit for 1-day exposure | Concentration of a chemical in drinking water that is not expected to cause any adverse, noncarcinogenic health effects for up to one day of exposure. The One-Day health-based limit (or Health Advisory, HA) is typically set to protect a 10-kg child consuming 1 liter of water per day. Source: U.S. Environmental Protection Agency. | 20000 ppb |
| Children's health-based limit for 10-day exposure | Concentration of a chemical in drinking water that is not expected to cause any adverse, noncarcinogenic effects for up to ten days of exposure. The Ten-Day health-based limit (or Health Advisory, HA) is typically set to protect a 10-kg child consuming 1 liter of water per day. Source: U.S. Environmental Protection Agency. | 20000 ppb |
| Drinking Water Equivalent Level | A lifetime exposure concentration protective of adverse, noncarcinogenic health effects, that assumes all of the exposure to a contaminant is from drinking water. Source: U.S. Environmental Protection Agency. | 20000 ppb |
Testing Summary for Di(2-Ethylhexyl) adipate
| Are tests routinely required for Di(2-Ethylhexyl) adipate by federal law? | Yes |
| Water suppliers reporting tests for Di(2-Ethylhexyl) adipate (2004-2009): | 18,324 of 47,576 |
| Average testing rate for water supplier reporting tests (2004-2009): | 0.5 per year |
Violation Summary for Di(2-Ethylhexyl) adipate
Data from the U.S. Environmental Protection Agency includes the following violations of federal standards for Di(2-Ethylhexyl) adipate since 2004
| Maximum Contaminant Level Exceedance Violations | 0 |
| Monitoring Violations | 1,866 |
| Reporting Violations | 0 |
Cancer
| Type of concern: | Reference: |
| Limited evidence of carcinogenicity | EPA Integrated Risk Information System (IRIS) |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Carcinogenesis (London) 1987 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Mutation Research 1995 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Toxicology and Applied Pharmacology 1975 |
| One or more in vitro tests on mammalian cells show positive mutation results | RTECS®- Environmental and Molecular Mutagenesis 1987 |
| One or more in vitro tests non-mammalian cells show positive mutation results | RTECS®- Mutation Research 1991 |
| One or more animal studies show tumor formation at high doses | RTECS®- National Toxicology Program Technical Report Series 1981 |
| One or more animal studies show tumor formation at high doses | RTECS®- EHP, Environmental Health Perspectives 1986 |
| One or more animal studies show tumor formation at high doses | RTECS®- National Technical Information Service 5927 |
| Cancer - not classifiable/not likely to be human carcinogen | Int'l Agency for Research on Cancer (IARC) - Carcinogens |
Organ system toxicity (non-reproductive)
| Type of concern: | Reference: |
| Classified as a high human health priority | Environment Canada Domestic Substance List |
| Classified as expected to be toxic or harmful | Environment Canada Domestic Substance List |
| One or more animal studies show classified as toxic effects at low doses | EPA Categorized List of Inert Pesticide Ingredients |
| One or more animal studies show classified as toxic effects at moderate doses (low dose studies may be unavailable for this ingredient) | EPA Toxic Release Inventory PBTs |
| One or more animal studies show blood effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Toxicology Letters 1982 |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Toxicology 1997 |
| One or more animal studies show metabolic effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Toxicology 1997 |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Beratergremium fuer umweltrelevante Altstoffe (BUA 1997 |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Archives of Toxicology 1988 |
| One or more animal studies show metabolic effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Reproductive Toxicology 2003 |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Reproductive Toxicology 2006 |
| One or more animal studies show metabolic effects at high doses (low dose studies may be unavailable for this ingredient) | RTECS®- Reproductive Toxicology 2006 |
Endocrine disruption
| Type of concern: | Reference: |
| Limited evidence of endocrine disruption | Japanese National Institute of Health Sciences |
| endocrine - weight of evidence unknown/unassessed/unreview: published lit review or major tox study | Illinois EPA Chemicals Associated with Endocrine System |
Developmental/reproductive toxicity
| Type of concern: | Reference: |
| One or more animal studies show reproductive effects at high doses | RTECS®- Journal of Pharmaceutical Sciences 1973 |
| One or more animal studies show reproductive effects at high doses | RTECS®- Reproductive Toxicology 2003 |
Biochemical or cellular level changes
| Type of concern: | Reference: |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | RTECS®- Toxicology 1997 |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | RTECS®- Beratergremium fuer umweltrelevante Altstoffe (BUA 1997 |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | RTECS®- Archives of Toxicology 1988 |
Ecotoxicology
| Type of concern: | Reference: |
| Wildlife and environmental toxicity | Illinois EPA Chemicals Associated with Endocrine System |
| Suspected to be an environmental toxin | Environment Canada Domestic Substance List |
Persistence and bioaccumulation
| Type of concern: | Reference: |
| Not suspected to be persistent | Environment Canada Domestic Substance List |
| Not suspected to be bioaccumulative | Environment Canada Domestic Substance List |
Government, industry, academic studies and classifications
| government/industry list/academic study | appears on list as | classification(s) |
| Cosmetic Ingredient Review Assessments | DIETHYLHEXYL ADIPATE | •Safe as used in cosmetics according to industry panel (Cosmetic Ingredient Review, CIR) •Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product |
| Cosmetic Ingredient Review Assessments | DIOCTYL ADIPATE | •Safe as used in cosmetics according to industry panel (Cosmetic Ingredient Review, CIR) •Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product |
| Environment Canada Domestic Substance List | HEXANEDIOIC ACID, BIS(2-ETHYLHEXYL) ESTER | •This chemical was deemed a high human health priority and was flagged by CEPA for further attention. The chemical is suspected to be carcinogenic and suspected of aquatic toxicity. |
| Illinois EPA Chemicals Associated with Endocrine System | DI(2-ETHYLHEXYL)ADIPATE | •EPA: suspected endocrine disruptor |
| EPA Integrated Risk Information System (IRIS) | DI(2-ETHYLHEXYL)ADIPATE | •Group C: Possible human carcinogen (EPA classification) |
| European Commission on Endocrine Disruption | BIS(2-ETHYLHEXYL)ADIPATE | HH-CAT3b;WF-CAT3b |
| IFRA Fragrance Ingredient List | DI-(2-ETHYLHEXYL) ADIPATE | •The chemical has been reported as used in fragrance compounds by IFRA affiliated member companies in 2008. |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | DI(2-ETHYLHEXYL) ADIPATE | •IARC Group 3 (no cancer link) |
| EPA Categorized List of Inert Pesticide Ingredients | ADIPIC ACID, BIS(2-ETHYLHEXYL) ESTER | •Pesticide inerts of toxicological concern according to EPA (Environmental Protection Agency) |
| EPA Toxic Release Inventory PBTs | BIS(2ETHYLHEXYL) ESTERHEXANEDIOIC ACID | •Toxic, U.S. Environmental Protection Agency Toxics Release Inventory programs |
| Japanese National Institute of Health Sciences | BIS(2-ETHYLHEXYL) ADIPATE | •Endocrine toxicity hazards: suspected |
| RTECS®- Archives of Toxicology 1988 | DIETHYLHEXYL ADIPATE | • biochemical - Lipids, including transport (rat TDLo) • liver - Other changes (rat TDLo) |
| RTECS®- Beratergremium fuer umweltrelevante Altstoffe (BUA 1997 | DIETHYLHEXYL ADIPATE | • liver - Changes in liver weight (mouse TDLo) • biochemical - Lipids, including transport (mouse TDLo) • liver - Liver function tests impaired (mouse TDLo) |
| RTECS®- Carcinogenesis (London) 1987 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (rat orl) |
| RTECS®- Carcinogenesis (London) 1987 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Unscheduled DNA Synthesis (rat orl) |
| RTECS®- EHP, Environmental Health Perspectives 1986 | DIETHYLHEXYL ADIPATE | • cancer - liver tumors (mouse TD) |
| RTECS®- Environmental and Molecular Mutagenesis 1987 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Cytogenetic Analysis (hamster ovr) |
| RTECS®- Environmental and Molecular Mutagenesis 1987 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Cytogenetic Analysis (hamster ovr) |
| RTECS®- Journal of Pharmaceutical Sciences 1973 | DIETHYLHEXYL ADIPATE | • reproductive - Fetotoxicity (rat TDLo) • reproductive - Other developmental abnormalities (rat TDLo) |
| RTECS®- Mutation Research 1991 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Phage Inhibition Capacity (Escherichia coli ) |
| RTECS®- Mutation Research 1995 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: other mutation test systems (mouse orl) |
| RTECS®- Mutation Research 1991 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Phage Inhibition Capacity (Escherichia coli ) |
| RTECS®- Mutation Research 1995 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: other mutation test systems (mouse orl) |
| RTECS®- National Technical Information Service 5927 | DIETHYLHEXYL ADIPATE | • cancer - liver tumors (mouse TDLo) |
| RTECS®- National Toxicology Program Technical Report Series 1981 | DIETHYLHEXYL ADIPATE | • cancer - liver tumors (mouse TDLo) |
| RTECS®- Reproductive Toxicology 2003 | DIETHYLHEXYL ADIPATE | • reproductive - Growth statistics (rat TDLo) • reproductive - Hepatobiliary system (rat TDLo) • reproductive - Parturition (rat TDLo) • reproductive - Post-implantation mortality (rat TDLo) • reproductive - Viability index (rat TDLo) • metabolic - Weight loss or decreased weight gain (rat TDLo) |
| RTECS®- Reproductive Toxicology 2006 | DIETHYLHEXYL ADIPATE | • metabolic - Weight loss or decreased weight gain (rat TDLo) • liver - Changes in liver weight (rat TDLo) |
| RTECS®- Toxicology and Applied Pharmacology 1975 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Dominant Lethal Strain (mouse ipr) |
| RTECS®- Toxicology and Applied Pharmacology 1975 | DIETHYLHEXYL ADIPATE | • mutagenic - Positive mutation assay: Dominant Lethal Strain (mouse ipr) |
| RTECS®- Toxicology Letters 1982 | DIETHYLHEXYL ADIPATE | • blood - Changes in serum composition (eg., TP, bilirubin, cholesterol) (rat TDLo) |
| RTECS®- Toxicology 1997 | DIETHYLHEXYL ADIPATE | • metabolic - Weight loss or decreased weight gain (rat TDLo) • liver - Changes in liver weight (rat TDLo) • biochemical - Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) (rat TDLo) • liver - Other changes (mouse TDLo) |
references
| government/industry list/academic study | reference |
| Cosmetic Ingredient Review Assessments | CIR (Cosmetic Ingredient Review). 2006. CIR Compendium, containing abstracts, discussions, and conclusions of CIR cosmetic ingredient safety assessments. Washington DC. |
| Environment Canada Domestic Substance List | EC (Environment Canada). 2008. Domestic Substances List Categorization. Canadian Environmental Protection Act (CEPA) Environmental Registry. |
| Illinois EPA Chemicals Associated with Endocrine System | Illinois EPA (Illinois Environmental Protection Agency). 2000. Preliminary list of chemicals associated with endocrine system effects in animals and humans (*) or in vitro (+). In EPA (U.S. Environmental Protection Agency) 2000. Handbook for Non-Cancer Health Effects Valuation, Appendix C. |
| EPA Integrated Risk Information System (IRIS) | EPA (U.S. Environmental Protection Agency). 2008. Integrated Risk Information System (IRIS). Evidence for human carcinogenicity based on 1986-2005 guidelines. |
| European Commission on Endocrine Disruption | EU (European Union)- Strategy for Endocrine Disrupters 2007. Commision on endocrin disruption requested by the European Parliament in 1998. |
| IFRA Fragrance Ingredient List | IFRA (International Fragrance Assocication). 2010. IFRA Fragrance Ingredient List based on 2008 Use Survey. Accessed online 01/04/2010: http://www.ifraorg.org/Home/News/Latest-News/page.aspx/66?xf_itemId=43&xf_selectionDatapartId=25 |
| Int'l Agency for Research on Cancer (IARC) - Carcinogens | IARC (International Agency for Research on Cancer). 2008. Overall Evaluations of Carcinogenicity to Humans, as evaluated in IARC Monographs Volumes 1-99 (a total of 935 agents, mixtures and exposures). |
| EPA Categorized List of Inert Pesticide Ingredients | EPA (U.S. Environmental Protection Agency). 1987 & 2005. Office of Pesticide Programs. Inert (other) Pesticide Ingredients in Pesticide Products - Categorized List of Inert (other) Pesticide Ingredients. |
| EPA Toxic Release Inventory PBTs | EPA (U.S. Environmental Protection Agency). 1999. Toxics Release Inventory Program. PBT Chemical Rule. |
| Scorecard.org Toxicity Information | Japanese National Institute of Health Sciences. Lists of Paradigmatic Chemicals. http://www.nihs.go.jp/hse/endocrine-e/paradigm/paradigm.html |
| RTECS®- Archives of Toxicology 1988 | RTECS®- Archives of Toxicology. (Springer-Verlag, Heidelberger Pl. 3, D-1000 Berlin 33, Fed. Rep. Ger.) V.32- 1974- Suppl.12,274,1988 |
| RTECS®- Beratergremium fuer umweltrelevante Altstoffe (BUA 1997 | RTECS®- Beratergremium fuer umweltrelevante Altstoffe (BUA. Gesellschaft Deutscher Chemiker. Weinheim ; New York : VCH) 1992- -,153,1997 |
| RTECS®- Carcinogenesis (London) 1987 | RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- 8,1433,1987 |
| RTECS®- Carcinogenesis (London) 1987 | RTECS®- Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 8,1433,1987 |
| RTECS®- EHP, Environmental Health Perspectives 1986 | RTECS®- EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- 65,271,1986 |
| RTECS®- Environmental and Molecular Mutagenesis 1987 | RTECS®- Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- 10(Suppl 10),1,1987 |
| RTECS®- Environmental and Molecular Mutagenesis 1987 | RTECS®- Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 10(Suppl 10),1,1987 |
| RTECS®- Journal of Pharmaceutical Sciences 1973 | RTECS®- Journal of Pharmaceutical Sciences. (American Pharmaceutical Assoc., 2215 Constitution Ave., NW, Washington, DC 20037) V.50- 1961- 62,1596,1973 |
| RTECS®- Mutation Research 1991 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 260,349,1991 |
| RTECS®- Mutation Research 1995 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 343,157,1995 |
| RTECS®- Mutation Research 1991 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 260,349,1991 |
| RTECS®- Mutation Research 1995 | RTECS®- Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- -1964 343,157,1995 |
| RTECS®- National Technical Information Service 5927 | RTECS®- National Technical Information Service. (Springfield, VA 22161) Formerly U.S. Clearinghouse for Scientific & Technical Information. PB82-185927 |
| RTECS®- National Toxicology Program Technical Report Series 1981 | RTECS®- National Toxicology Program Technical Report Series. (Research Triangle Park, NC 27709) No.206- NTP-TR-212,1981 |
| RTECS®- Reproductive Toxicology 2003 | RTECS®- Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- 17,163,2003 |
| RTECS®- Reproductive Toxicology 2006 | RTECS®- Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY 10523) V.1- 1987- 21,253,2006 |
| RTECS®- Toxicology and Applied Pharmacology 1975 | RTECS®- Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- 32,566,1975 |
| RTECS®- Toxicology and Applied Pharmacology 1975 | RTECS®- Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 32,566,1975 |
| RTECS®- Toxicology Letters 1982 | RTECS®- Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977- 10,379,1982 |
| RTECS®- Toxicology 1997 | RTECS®- Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- 123,217,1997 |
"RTECS®" is a United States trademark owned and licensed under authority of the U.S. Government, by and through MDL Information Systems, Inc.
